IGC Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD) March 12, 2018September 10, 2019 by charlie
IGC Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD) March 1, 2018September 10, 2019 by charlie
IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage February 20, 2018September 10, 2019 by charlie
IGC’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13 February 12, 2018September 10, 2019 by charlie
IGC Reports Promising Spatial Memory Results in Alzheimer’s Study January 2, 2018September 10, 2019 by charlie
IGC to Use Blockchain to Address Issues Specific to the Medical Cannabis Industry December 26, 2017September 10, 2019 by charlie
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017 December 18, 2017September 10, 2019 by charlie
